Variant report

Variant	esv3405799
Chromosome Location	chr4:121842552-121845050
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:352)
CpG islands
(count:732)
Chromatin interactive
region (count:1)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:352 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr4:121843946-121844357	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr4:121842876-121843475	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr4:121843793-121844283	H1-hESC	embryonic stem cell:	n/a	n/a
4	BRCA1	chr4:121844130-121844311	H1-hESC	embryonic stem cell:	n/a	n/a
5	CEBPB	chr4:121842858-121843416	Hela-S3	cervix:	n/a	n/a
6	CEBPB	chr4:121844151-121844381	H1-hESC	embryonic stem cell:	n/a	n/a
7	CHD1	chr4:121843874-121844514	H1-hESC	embryonic stem cell:	n/a	n/a
8	CHD1	chr4:121843058-121843437	H1-hESC	embryonic stem cell:	n/a	n/a
9	CHD2	chr4:121843773-121844441	H1-hESC	embryonic stem cell:	n/a	n/a
10	CHD2	chr4:121843777-121843898	Hela-S3	cervix:	n/a	n/a
11	CREB1	chr4:121843861-121844161	A549	lung:	n/a	n/a
12	CREB1	chr4:121843079-121843564	A549	lung:	n/a	n/a
13	CTBP2	chr4:121842928-121844414	H1-hESC	embryonic stem cell:	n/a	n/a
14	CTCF	chr4:121843300-121843450	SK-N-SH_RA	brain:	n/a	n/a
15	CTCF	chr4:121843720-121843870	AG10803	skin:	n/a	n/a
16	CTCF	chr4:121843695-121843999	H1-hESC	embryonic stem cell:	n/a	n/a
17	CTCF	chr4:121843740-121843890	HRE	kidney:	n/a	n/a
18	CTCF	chr4:121844220-121844370	Caco-2	colon:	n/a	n/a
19	CTCF	chr4:121843860-121844010	HCT-116	colon:	n/a	n/a
20	CTCF	chr4:121843720-121843870	NHDF-neo	bronchial:	n/a	n/a
21	CTCF	chr4:121843760-121843910	SAEC	small airway:	n/a	n/a
22	CTCF	chr4:121843780-121843930	AG09319	gingival:	n/a	n/a
23	CTCF	chr4:121843720-121843870	MCF-7	breast:	n/a	n/a
24	CTCF	chr4:121843306-121843471	MCF-7	breast:	n/a	n/a
25	CTCF	chr4:121843820-121843970	BE2_C	brain:	n/a	n/a
26	CTCF	chr4:121843640-121843790	HCM	heart:	n/a	n/a
27	CTCF	chr4:121843700-121843850	BE2_C	brain:	n/a	n/a
28	CTCF	chr4:121843660-121843810	RPTEC	kidney:	n/a	n/a
29	CTCF	chr4:121843720-121843870	HMF	breast:	n/a	n/a
30	CTCF	chr4:121844280-121844430	NHDF-neo	bronchial:	n/a	n/a
31	CTCF	chr4:121843744-121843756	A549	lung:	n/a	n/a
32	CTCF	chr4:121843340-121843490	AG09319	gingival:	n/a	n/a
33	CTCF	chr4:121843727-121843851	MCF-7	breast:	n/a	n/a
34	CTCF	chr4:121843020-121843170	HPF	lung:	n/a	n/a
35	CTCF	chr4:121843620-121843890	NHEK	skin:	n/a	n/a
36	CTCF	chr4:121843429-121843503	H1-hESC	embryonic stem cell:	n/a	n/a
37	CTCF	chr4:121843720-121843870	HUVEC	blood vessel:	n/a	n/a
38	CTCF	chr4:121843320-121843470	AG04449	skin:	n/a	n/a
39	CTCF	chr4:121843840-121843990	AG04450	lung:	n/a	n/a
40	CTCF	chr4:121843796-121843837	NHEK	skin:	n/a	n/a
41	CTCF	chr4:121843425-121843427	MCF-7	breast:	n/a	n/a
42	CTCF	chr4:121843360-121843510	AG04449	skin:	n/a	n/a
43	CTCF	chr4:121843740-121843890	AG04449	skin:	n/a	n/a
44	CTCF	chr4:121843820-121843970	HEK293	kidney:	n/a	n/a
45	CTCF	chr4:121844060-121844210	HUVEC	blood vessel:	n/a	n/a
46	CTCF	chr4:121843120-121843175	NHEK	skin:	n/a	n/a
47	CTCF	chr4:121843720-121843870	AoAF	blood vessel:	n/a	n/a
48	CTCF	chr4:121843740-121843890	WI-38	lung:	n/a	n/a
49	CTCF	chr4:121843740-121843890	NHEK	skin:	n/a	n/a
50	CTCF	chr4:121843720-121843870	GM12875	blood:	n/a	n/a

(count:732 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:121843717-121843767	HRPEpiC	eye:	n/a
2	chr4:121844401-121844451	PFSK-1	brain:	n/a
3	chr4:121842998-121843048	HUVEC	blood vessel:	n/a
4	chr4:121844186-121844236	ECC-1	luminal epithelium:	n/a
5	chr4:121844284-121844334	HNPCEpiC	eye:	n/a
6	chr4:121844259-121844309	NH-A	brain:	n/a
7	chr4:121843785-121843835	BE2_C	brain:	n/a
8	chr4:121844401-121844451	Hela-S3	cervix:	n/a
9	chr4:121844192-121844242	LNCaP	prostate:	n/a
10	chr4:121844186-121844236	SK-N-SH_RA	brain:	n/a
11	chr4:121844176-121844226	U87	brain:	n/a
12	chr4:121843207-121843257	SKMC	muscle:	n/a
13	chr4:121843035-121843085	HCM	heart:	n/a
14	chr4:121842998-121843048	MCF-7	breast:	n/a
15	chr4:121843717-121843767	HNPCEpiC	eye:	n/a
16	chr4:121843785-121843835	HRCEpiC	kidney:	n/a
17	chr4:121843035-121843085	SK-N-MC	brain:	n/a
18	chr4:121844192-121844242	SK-N-SH	brain:	n/a
19	chr4:121844284-121844334	NHDF-neo	bronchial:	n/a
20	chr4:121844401-121844451	PrEC	prostate:	n/a
21	chr4:121844186-121844236	GM12878	blood:	n/a
22	chr4:121843785-121843835	HCPEpiC	choroid plexus:	n/a
23	chr4:121843207-121843257	HIPEpiC	eye:	n/a
24	chr4:121844284-121844334	NB4	blood:	n/a
25	chr4:121843717-121843767	HCM	heart:	n/a
26	chr4:121844259-121844309	HMEC	breast:	n/a
27	chr4:121844401-121844451	HMEC	breast:	n/a
28	chr4:121844401-121844451	SKMC	muscle:	n/a
29	chr4:121844401-121844451	MCF10A-Er-Src	breast:	n/a
30	chr4:121844259-121844309	AG09309	skin:	n/a
31	chr4:121843785-121843835	SK-N-MC	brain:	n/a
32	chr4:121844186-121844236	H1-hESC	embryonic stem cell:	embryo
33	chr4:121844259-121844309	NT2-D1	testis:	n/a
34	chr4:121844186-121844236	IMR90	lung:	fetal
35	chr4:121844186-121844236	PFSK-1	brain:	n/a
36	chr4:121843207-121843257	MCF10A-Er-Src	breast:	n/a
37	chr4:121844176-121844226	SK-N-MC	brain:	n/a
38	chr4:121844259-121844309	HL-60	blood:	n/a
39	chr4:121844401-121844451	H1-hESC	embryonic stem cell:	embryo
40	chr4:121843717-121843767	Jurkat	blood:	n/a
41	chr4:121844174-121844224	BE2_C	brain:	n/a
42	chr4:121844192-121844242	HMEC	breast:	n/a
43	chr4:121842998-121843048	HCF	heart:	n/a
44	chr4:121844259-121844309	HEK293	kidney:	embryo
45	chr4:121843207-121843257	AG04449	skin:	fetal
46	chr4:121843785-121843835	HCF	heart:	n/a
47	chr4:121842998-121843048	NB4	blood:	n/a
48	chr4:121844174-121844224	HMEC	breast:	n/a
49	chr4:121844401-121844451	AoSMC	blood vessel:	n/a
50	chr4:121842998-121843048	HCPEpiC	choroid plexus:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr4:121836736..121838271-chr4:121841875..121843483,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AC079341.1-10	chr4:121843097-121844760	NONHSAT098131

No data

Variant related genes	Relation type
PRDM5	TF binding region
PRDM5	CpG island

Extended variants
information (count: 100 )
Associated
traits (count: 74 )

Variant overlapped rSNPs/rCNVs (count:100 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs376474667	chr4:121842564-121842565	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs1470696	chr4:121842567-121842568	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
3	rs35844372	chr4:121842614-121842615	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
4	rs1470695	chr4:121842617-121842618	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs562580823	chr4:121842655-121842656	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
6	rs76978864	chr4:121842672-121842673	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
7	rs559645749	chr4:121842683-121842684	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
8	rs545511934	chr4:121842697-121842698	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
9	rs565320786	chr4:121842723-121842724	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
10	rs72680495	chr4:121842729-121842730	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs190945517	chr4:121842789-121842790	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
12	rs59143824	chr4:121842800-121842801	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs567918791	chr4:121842839-121842840	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs182211344	chr4:121842875-121842876	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs549800215	chr4:121842895-121842896	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs569697069	chr4:121842930-121842931	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs79583078	chr4:121842970-121842971	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs558589127	chr4:121843035-121843036	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs142257180	chr4:121843134-121843135	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	lncRNA	n/a	Overlapped CNVs	n/a
20	rs186557672	chr4:121843163-121843164	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	lncRNA	n/a	Overlapped CNVs	n/a
21	rs554351551	chr4:121843166-121843167	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	lncRNA	n/a	Overlapped CNVs	n/a
22	rs373447990	chr4:121843175-121843176	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	lncRNA	n/a	Overlapped CNVs	n/a
23	rs574378506	chr4:121843208-121843209	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
24	rs533474235	chr4:121843232-121843233	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
25	rs190165270	chr4:121843244-121843245	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
26	rs556113635	chr4:121843270-121843271	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
27	rs534469622	chr4:121843283-121843284	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
28	rs72923591	chr4:121843317-121843318	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs545089098	chr4:121843351-121843352	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
30	rs565350655	chr4:121843369-121843370	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
31	rs527786077	chr4:121843395-121843396	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
32	rs541636331	chr4:121843431-121843432	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
33	rs370967932	chr4:121843451-121843452	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
34	rs145796270	chr4:121843460-121843461	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
35	rs3761726	chr4:121843469-121843470	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs367675022	chr4:121843500-121843501	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
37	rs570271290	chr4:121843523-121843524	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
38	rs532106810	chr4:121843530-121843531	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
39	rs551890994	chr4:121843551-121843552	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
40	rs565726144	chr4:121843557-121843558	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
41	rs182473991	chr4:121843601-121843602	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
42	rs554337420	chr4:121843609-121843610	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
43	rs113037077	chr4:121843611-121843612	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
44	rs373747340	chr4:121843622-121843623	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
45	rs376502646	chr4:121843625-121843626	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
46	rs369323461	chr4:121843638-121843639	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
47	rs556976941	chr4:121843651-121843652	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
48	rs373822101	chr4:121843685-121843686	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
49	rs148449361	chr4:121843707-121843708	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
50	rs377348597	chr4:121843718-121843719	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:74)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Breast cancer	16272173	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Myelodysplastic syndrome	21251322	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	21183584	CNVD
primary effusion lymphomas	17116491	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17133270	CNVD
Colorectal cancer	20459617	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Esophageal cancer	21851588	CNVD
Colorectal cancer	16272173	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Neuroblastoma	21899760	CNVD
Renal cell carcinoma	18194544	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Myelofibrosis	22110671	CNVD
small cell lung cancer	20016488	CNVD
Clear cell renal cell carcinoma	18791270	CNVD
Acute myeloid leukemia	19651601	CNVD
Gastric cancer	16891809	CNVD
Olfactory neuroblastoma	18408657	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:438 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:121814600-121842600	Weak transcription	Right Ventricle	heart
2	chr4:121825000-121842600	Weak transcription	Fetal Muscle Trunk	muscle
3	chr4:121837000-121842800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr4:121837400-121842600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
5	chr4:121838400-121842600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
6	chr4:121838400-121842600	Weak transcription	Gastric	stomach
7	chr4:121839200-121842600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
8	chr4:121839200-121842600	Enhancers	Fetal Intestine Small	intestine
9	chr4:121839400-121842600	Enhancers	Breast Myoepithelial Primary Cells	Breast
10	chr4:121840000-121842600	Enhancers	Colon Smooth Muscle	Colon
11	chr4:121840000-121842600	Enhancers	Stomach Smooth Muscle	stomach
12	chr4:121840200-121842600	Weak transcription	Esophagus	oesophagus
13	chr4:121840200-121842600	Weak transcription	Left Ventricle	heart
14	chr4:121840200-121842800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
15	chr4:121840400-121842600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
16	chr4:121840400-121842600	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
17	chr4:121840400-121842600	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
18	chr4:121840400-121842600	Weak transcription	Fetal Muscle Leg	muscle
19	chr4:121840400-121842600	Weak transcription	Small Intestine	intestine
20	chr4:121840400-121842600	Weak transcription	Monocytes-CD14+_RO01746	blood
21	chr4:121840400-121842800	Weak transcription	Aorta	Aorta
22	chr4:121840600-121842600	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
23	chr4:121840600-121842600	Weak transcription	Brain Substantia Nigra	brain
24	chr4:121840600-121842600	Weak transcription	Fetal Stomach	stomach
25	chr4:121840600-121842600	Weak transcription	Psoas Muscle	Psoas
26	chr4:121840600-121842600	Weak transcription	Skeletal Muscle Male	skeletal muscle
27	chr4:121841000-121842600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
28	chr4:121841000-121842600	Weak transcription	Colonic Mucosa	Colon
29	chr4:121841000-121842600	Weak transcription	Fetal Kidney	kidney
30	chr4:121841600-121842600	Enhancers	Osteobl	bone
31	chr4:121841800-121842600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
32	chr4:121841800-121842600	Weak transcription	H9 Cell Line	embryonic stem cell
33	chr4:121841800-121842600	Weak transcription	Ovary	ovary
34	chr4:121841800-121842600	Enhancers	Hela-S3	cervix
35	chr4:121841800-121842800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
36	chr4:121841800-121843000	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
37	chr4:121841800-121843000	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
38	chr4:121841800-121844600	Active TSS	iPS-20b Cell Line	embryonic stem cell
39	chr4:121842000-121842600	Enhancers	Fetal Lung	lung
40	chr4:121842200-121842600	Weak transcription	H1 Cell Line	embryonic stem cell
41	chr4:121842200-121842600	Enhancers	Adipose Nuclei	Adipose
42	chr4:121842200-121842600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
43	chr4:121842200-121842800	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
44	chr4:121842200-121842800	Enhancers	Cortex derived primary cultured neurospheres	brain
45	chr4:121842200-121843000	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
46	chr4:121842200-121843000	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
47	chr4:121842400-121842600	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
48	chr4:121842400-121842600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
49	chr4:121842400-121842600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
50	chr4:121842400-121842600	Bivalent Enhancer	Primary T cells from cord blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links